NRGO:NYE-MicroSectors U.S. Big Oil Index 2X Leveraged ETNs

COMMON STOCK | Others |

Last Closing

USD 47.228

Change

0.00 (0.00)%

Market Cap

N/A

Volume

N/A

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2019-09-19 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
SOJE SOJE

+0.07 (+0.37%)

USD 65.72B
JEPI JPMorgan Equity Premium Income..

-0.12 (-0.22%)

USD 32.78B
LCR Leuthold Core ETF

-0.09 (-0.28%)

USD 32.52B
DTB DTB

+0.21 (+1.12%)

USD 26.58B
DFAC Dimensional U.S. Core Equity 2..

-0.17 (-0.56%)

USD 26.11B
JPST JPMorgan Ultra-Short Income ET..

+0.02 (+0.04%)

USD 22.47B
SGOV iShares® 0-3 Month Treasury B..

+0.03 (+0.03%)

USD 18.58B
TSPA T. Rowe Price US Equity Resear..

-0.20 (-0.64%)

USD 16.23B
DFUV Dimensional US Marketwide Valu..

-0.13 (-0.34%)

USD 10.15B
AVUV Avantis® U.S. Small Cap Value..

-0.83 (-0.95%)

USD 10.05B

ETFs Containing NRGO

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain N/A N/A N/A N/A F
Dividend Return N/A N/A N/A N/A F
Total Return N/A N/A N/A N/A F
Trailing 12 Months  
Capital Gain N/A N/A N/A N/A F
Dividend Return N/A N/A N/A N/A F
Total Return N/A N/A N/A N/A F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A F
Dividend Return N/A N/A N/A N/A F
Total Return N/A N/A N/A N/A F
Average Annual (5 Year Horizon)  
Capital Gain N/A N/A N/A N/A F
Dividend Return N/A N/A N/A N/A F
Total Return N/A N/A N/A N/A F
Risk Return Profile  
Volatility (Standard Deviation) N/A N/A N/A N/A F
Risk Adjusted Return N/A N/A N/A N/A F
Market Capitalization N/A N/A N/A N/A F

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:

There is nothing we particularly dislike